DP

Devrav Parihar

Active Director Director DIN 10845723
DIN 10845723 First appointment Nov 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Devrav Parihar

Data last updated:

Devrav Parihar is a Director at Curelock Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10845723
Primary Designation Director
Industry Pharma
First Appointment 21 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Nov 20242024Active

Board colleagues of Devrav Parihar

NameDINCompanyDesignation
Gulshan Parihar10845722Curelock Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Curelock Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Devrav Parihar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devrav Parihar

Devrav Parihar currently holds 1 directorship: Curelock Pharmaceuticals Private Limited (Director, since 21 Nov 2024).

Devrav Parihar was first appointed on 21 Nov 2024 as Director at Curelock Pharmaceuticals Private Limited.

The current boards of Devrav Parihar's companies include Gulshan Parihar (Curelock Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available